21st Century Cures Becomes Law- Provide New Funds for NIH and Opioid Crisis
On December 13, President Obama signed into law H.R. 34, the 21st Century Cures Act, a bipartisan piece of legislation Congress had been negotiating since the original bill passed the U.S. House of Representatives in July 2015. The bill affects primarily the Food and Drug Administration and the National Institutes of Health (NIH) and includes provisions intended to improve mental health, building on recommendations from the President’s Mental Health and Substance Use Disorder Parity Taskread more
Congress Adjourns, Funding Federal Government Through April 2017
On December 9, with only hours remaining before funding for the federal government expired, Congress passed and the President signed, a continuing resolution (CR) (H.R. 2028) extending Fiscal Year (FY) 2016 funding through April 28, 2017. The stopgap measure allows Congress to complete work on the FY 2017 spending bills in the 115th Congress, which will convene in January.
With FY 2017 having officially begun on October 1, the CR extends FY 2016 by about seven months. A major disadvantage ofread more
NSF Reauthorization Bill Advances in Senate
The long-awaited Senate bill to reauthorize programs at the National Science Foundation and other science agencies was released in late June and greeted with cautious enthusiasm by the science and higher education communities.
S.3084, the American Innovation and Competitiveness Act
reaffirms NSF’s merit-based peer review process;
reduces administrative burdens on researchers;
addresses broadening participation of women and minorities in STEM;
and directs the Office of
Key Funding Bill Moves in U.S. House of Representative
On July 14, the House Appropriations Committee, on a vote of 31-19, reported out the Fiscal Year 2017 Labor, Health and Human Services, and Education Appropriations bill. The bill funds several federal agencies important to FABBS members, including the National Institutes of Health (NIH) and Institute of Education Sciences (IES).
The bill boosts the NIH to $33.3 billion in FY 2017—an amount $1.2 billion above the agency’s FY 2016 enacted level and $2.2 billion more than the